Previous 10 | Next 10 |
Kahn Brothers’ 13F portfolio value increased from $579M to $646M this quarter. Stakes in VOXX International and BlackBerry were decreased during the quarter. The portfolio continues to be very concentrated with the top five positions accounting for ~45% of the 13F holdings....
Initiative Addresses Structural and Cultural Barriers to High-quality, Culturally Competent Health Care for Black and Hispanic Women; Delivers Innovative Health Research, Education and Access Model Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today...
Hologic (HOLX) announced that its subsidiary, Biotheranostics has received the broader Medicare coverage for the Breast Cancer Index test under an expanded Medicare Local Coverage Determination.Previously, Medicare-covered the test only for patients with node-negative, non-relapsed, estr...
InMode is a leader in the medical aesthetic devices industry and blows competitors out of the water when comparing financial metrics. The company still possesses many traits of a multi-bagger, such as having high revenue growth, stable margins, and high returns on capital. Our upd...
-- More women gain access to a test that helps determine whether extended endocrine therapy is appropriate for them -- Hologic, Inc. (Nasdaq: HOLX) announced today that its subsidiary, Biotheranostics, Inc., has received broader Medicare coverage for its Breast Cancer Index&...
After a dull 2020, value stocks are back in action. Amid the economy’s reopening, many fundamentally sound stocks that lost significant value last year have started rebounding. Furthermore, we think inflationary pressure in the United States and concerns over the market’s overva...
I doubt there is a person on this planet who doesn't want to see the COVID-19 pandemic disappear forever. But for businesses in the healthcare industry, the circumstances can end up generating additional revenue. That's not to say those companies don't want it to go away as everyone else do...
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – May 7, 2021 – A combination of medical applications for digital internet-of-things technologies coming into their own, and an explosion of interest in the healthcare sector spurred on by...
As positive economic data rolls in, investor confidence in a solid economic recovery is rising. Consequently, all the three major indexes are hitting new highs each week. And although investors continue to be concerned about rising Treasury yields and inflationary pressures, they appear pleas...
The #priceactio n in Hologic (NASDAQ: HOLX) can help investors find #opportunity and integrate #riskmanagement tools . Stock Traders Daily has demonstrated that in this article. Review The plans for HOLX below, and you will see how this works. Keep in mind, this ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-30 10:30:04 ET BTIG analyst issues NEUTRAL recommendation for HOLX on July 30, 2024 08:28AM ET. The previous analyst recommendation was Neutral. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current an...
2024-07-30 09:30:03 ET RBC Capital analyst issues SECTOR PERFORM recommendation for HOLX on July 30, 2024 07:43AM ET. The previous analyst recommendation was Sector Perform. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus ...
– Revenue of $1,011.4 Million, GAAP Diluted EPS of $0.82, and Non-GAAP Diluted EPS of $1.06; All Met or Exceeded Guidance – – Total Company Revenue Growth of 2.7%, or 3.1% in Constant Currency and 5.8% Organically excluding COVID-19; Against Growth of 18.4% in the Prior Y...